In a leadership move that signals Alembic Pharmaceuticals’ commitment to governance and financial stewardship, the company has appointed Rajkumar Baheti as Non-Executive Non-Independent Director, effective April 1, 2026. The decision, taken with the backing of the Board and shareholders via a postal ballot on March 31, reinforces Alembic’s intent to strengthen its governance framework with seasoned oversight at the helm of its board. Baheti will be liable to retire by rotation as part of the standard board practice.